Allergan to Buy Fat-Treatment Maker Zeltiq for $2.3 Billion
Allergan PLC said it would buy Zeltiq Aesthetics Inc., the maker of a fat-reducing treatment, for $2.26 billion. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 13, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Hospitals Weigh Difficult Choice Amid Travel-Ban Uncertainty
Hospital officials say President Donald Trump ’s executive order leaves them with a difficult choice: forgo strong residency candidates from countries named in the order or risk vacancies if foreign doctors are barred from the U.S. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 13, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
70-Fold Price Increase Puts Drug at $89,000
Marathon Pharmaceuticals will charge $89,000 annually in the U.S. for a decades-old steroidal drug that was approved for U.S. sale for the first time on Thursday, a price that is as much as 70 times higher than the drug ’s price overseas. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 11, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
Reckitt Benckiser to Buy Mead Johnson for $16.6 Billion
Reckitt Benckiser said it agreed to buy baby-food maker Mead Johnson for $16.6 billion, a cash deal that will almost double the size of the British company ’s consumer-health business and help it push deeper into emerging markets. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 10, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
As HHS Head, Price Has Wide Latitude to Shape Obamacare's Fate
The Georgia Republican was approved in a party-line vote Friday morning, placing him atop a sprawling agency tasked with dismantling the Affordable Care Act. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 10, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Federal Judge Blocks Anthem's Planned Cigna Buy
The decision said the proposed $48 billion deal violated antitrust law because it would create an unacceptable reduction in the number of companies serving large national employers that insure their workers. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 9, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
Report Cites Deficiencies at Theranos Lab
Theranos Inc. ’s lab in Arizona failed to ensure some patients who got potentially inaccurate diabetes test results were notified, according to a federal inspection report. It also performed patient blood-coagulation tests on a machine its staff configured improperly. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 9, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Federal Judge Blocks Anthem's Planned Acquisition of Cigna
The decision said the proposed $48 billion deal violated antitrust law because it would create an unacceptable reduction in the number of companies serving large national employers that insure their workers. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 9, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
Appeals Court Allows Sanofi, Regeneron to Continue Selling Cholesterol Drug
A U.S. federal appeals court said Sanofi SA and partner Regeneron Pharmaceuticals Inc. can keep selling their cholesterol drug while they challenge a patent-infringement ruling by a lower court that threatened to halt sales. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 9, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
In GOP, Divide Grows Over Pace of Obamacare Repeal
Conservative Republicans, worried about growing voices within the party advising or accepting a slower pace for repealing the Affordable Care Act, are redoubling their push to speed the GOP ’s long-desired goal. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 7, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Zenefits Picks Jay Fulcher as New CEO
Zenefits chose software executive Jay Fulcher as its new chief executive, the third person to lead the embattled health-benefits broker since early 2016. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 6, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Hospitals Fear Changes to ACA
Hospital executives are descending on Washington with a message: They are concerned about losing insured patients and revenue under any plan to dismantle or significantly alter the Affordable Care Act. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 6, 2017 Category: Pharmaceuticals Tags: FREE Source Type: news
Medicare Rates to See 'Moderate' Increase
Federal regulators proposed slightly higher payments for insurers that offer private Medicare plans, a closely watched figure because of the increasingly important role that the Medicare business plays in companies ’ bottom lines. (Source: WSJ.com: Health)
Source: WSJ.com: Health - February 1, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Federal Trade Commission Questions Mylan on EpiPen
Mylan said it received a “preliminary” inquiry from the Federal Trade Commission asking about the company’s commercial practices for its EpiPen severe-allergy treatments. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 30, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
Bristol-Myers Squibb Cuts Guidance on Cancer Drug Problems
Bristol-Myers Squibb Co. slashed its guidance for the year as the drugmaker contends with dimmed prospects for its top cancer drug after major setbacks during the final quarter of the year. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 26, 2017 Category: Pharmaceuticals Tags: PAID Source Type: news
